A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE)
Anna Liza M.P. de Leeuw, J. Giralt, Yungan Tao, Sergi Benavente, Thanh-Vân F. Nguyen, Frank Hoebers, Ann Hoeben, Chris H.J. Terhaard, Lip Wai Lee, Signe Friesland, Roel J.H.M. Steenbakkers, Lisa Tans, Jolien Heukelom, Mutamba T. Kayembe, Simon van Kranen, Harry Bartelink, C. Rasch, Jan‐Jakob Sonke, Olga Hamming‐Vrieze
Topics & Concepts
MedicineNuclear medicineToxicityHead and neck cancerHead and neck squamous-cell carcinomaRandomized controlled trialUrologyRadiation therapyInternal medicineSurgeryHead and Neck Cancer StudiesHead and Neck Surgical OncologyEsophageal Cancer Research and Treatment